Description: Outset Medical, Inc. is a rapidly growing medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. Its Tablo® Hemodialysis System (Tablo) represents a significant technological advancement enabling novel, transformational dialysis care in acute and home settings. Tablo was designed from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone.
Home Page: www.outsetmedical.com
OM Technical Analysis
3052 Orchard Drive
San Jose,
CA
95134
United States
Phone:
669 231 8200
Officers
| Name | Title |
|---|---|
| Ms. Leslie L. Trigg | CEO & Chairman |
| Mr. Nabeel Ahmed | CFO, Principal Financial Officer & Principal Accounting Officer |
| Mr. Martin Vazquez | Chief Operating Officer |
| Mr. Jean-Olivier Racine | Chief Technology Officer |
| Mr. John L. Brottem | Gen. Counsel & Sec. |
| Mr. James S. Mazzola | Head of Investor Relations |
| Nicole Shannon | Director of Marketing Communications |
| Ms. Stacey L. Porter | Chief People Officer |
| Dr. Michael Aragon M.D. | Chief Medical Officer |
| Ms. Tonya Saffer | Head of Gov. Affairs & Market Access |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 4.3755 |
| Price-to-Sales TTM: | 10.4222 |
| IPO Date: | 2020-09-15 |
| Fiscal Year End: | December |
| Full Time Employees: | 444 |